News | September 24, 2008

PEM Detects Most Difficult Cancers

September 25, 2008 – According to Naviscan Inc., positron emission mammography, or PEM, which uses advanced metabolic imaging to detect breast tumors in the crucial early stages, is giving doctors a new tool to help women beat breast cancer.

The Naviscan PEM Flex Solo II reportedly can produce high-resolution images of 2 mm resolution, allowing physicians to visualize the presence of tumors the size of a grain of rice.

The PEM Flex is similar to the size of a mammography unit and consists of two high-resolution detector heads mounted directly to breast immobilization paddles that are positioned to optimize imaging of the breast. The close proximity of crystal detectors and tomographic reconstruction produces the high-resolution images.

According to the company, an independent study showed that PEM technology is more sensitive than MRI in detecting the smallest cancers. PEM demonstrated 91 percent sensitivity in ductal carcinoma in situ (DCIS) compared with 83 percent with MRI and better sensitivity in cancers less than five millimeters in size. PEM also detected a 2 mm DCIS case to be shown negative on MRI.

Another study of 400 patients in a multi-center clinical trial comparing PEM with MRI will be completed this month, according to the company.

Kathy Schilling, M.D., medical director of the Center for Breast Cancer in Boca Raton, FL, said that in the study PEM can accurately detected the most difficult to see cancers. According to Dr. Schilling, “The ability to image and diagnose these early stage cancers provides the potential for cure and will significantly impact breast cancer management.”

For more information: www.naviscanpet.com

Related Content

Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...
Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA
News | Mammography | November 21, 2018
Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological...
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of AreYouDense.org.

News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor
Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who...